These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Menopause hormonal therapy from the urologist's perspective. Lightner DJ Curr Urol Rep; 2006 Jan; 7(1):1-3. PubMed ID: 16480661 [No Abstract] [Full Text] [Related]
4. The menopause and HRT. Urogenital effects of hormone therapy. Robinson D; Cardozo L Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):91-104. PubMed ID: 12763514 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and its effect on vaginal atrophy in post-menopausal women. Kelley C Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926 [TBL] [Abstract][Full Text] [Related]
6. Urogenital effects of the menopause. Schaffer J; Fantl JA Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):401-17. PubMed ID: 8931902 [No Abstract] [Full Text] [Related]
7. Postmenopausal vaginal atrophy and atrophic vaginitis. Pandit L; Ouslander JG Am J Med Sci; 1997 Oct; 314(4):228-31. PubMed ID: 9332260 [TBL] [Abstract][Full Text] [Related]
8. [Urogenital atrophy and recurrent urinary tract infection in elderly patients]. Salvat J; Capilna M; Schmidt MH Praxis (Bern 1994); 1997 Aug; 86(33):1249-53. PubMed ID: 9381010 [TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Beral V; Bull D; Reeves G; Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308 [TBL] [Abstract][Full Text] [Related]
10. Predictors of urinary tract infection after menopause: a prospective study. Jackson SL; Boyko EJ; Scholes D; Abraham L; Gupta K; Fihn SD Am J Med; 2004 Dec; 117(12):903-11. PubMed ID: 15629728 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor in pelvic floor tissues in patients with stress urinary incontinence. Zhu L; Lang J; Feng R; Chen J; Wong F Int Urogynecol J Pelvic Floor Dysfunct; 2004; 15(5):340-3. PubMed ID: 15580421 [TBL] [Abstract][Full Text] [Related]
12. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. North American Menopause Society Menopause; 2004; 11(6 Pt 1):589-600. PubMed ID: 15545786 [No Abstract] [Full Text] [Related]
13. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163 [TBL] [Abstract][Full Text] [Related]